Differentiation between malignant and benign nodules in the liver: Use of contrast C3-MODE technology

Figure 1 A: hepatocellular carcinoma; B: heterogenous high attenuation on contrast-enhanced CT; C: low echo on B-mode image; D: the hypervascularity in early arterial phase on contrast-enhanced C³-MODE technology; E: perfusion defect in the late phase on contrast-enhanced C³-MODE technology.

Figure 2 A: a 1. 5 cm-sized metastatic adenocacinoma in liver; B: low attenuation on contrast-enhanced CT; C: rim-like enhancement in early arterial phase (28 s) and perfusion defect (46-130 s) on contrast-enhanced C³-MODE technology.

Figure 3 A: a 4. 1 cm-sized hemangioma; B: heterogenous high attenuation on contrast-enhanced CT; C: hypoechoic lesion on B-mode image; D: the spot-like enhancement in early arterial phase on contrast-enhanced C³-MODE technology; E: centripetal filling in late phase (e) on contrast-enhanced C³-MODE technology.

Figure 4 A: a hyperechoic lesion; B: pathological diagnosis of fatty degeneration; C: the intranodular enhancement on contrast-enhanced C³-MODE technology in the early arterial phase; D: the intranodular enhancement in the late phase on contrast-enhanced C³-MODE technology.